Cure8 research brief
The work links a PD risk gene (LRRK2 G2019S) to increased intestinal NET formation and enteric α-synuclein in mouse colitis, suggesting a neutrophil-mediated inflammatory route by which gut inflammation and microbiota could influence PD-relevant pathology.
Researchers (PD, gut–brain axis, innate immunity, microbiome); clinicians following mechanistic research at the intersection of IBD and neurodegenerative disease.
The researchers used LRRK2 G2019S transgenic mice subjected to dextran sulfate sodium (DSS) colitis and a mix of ex vivo neutrophil experiments.
Mice with the mutation developed worse recurrent colitis and showed higher colonic NETs and enteric α-synuclein; interventions that reduced NETs (DNase I, PAD4 deficiency) lowered intestinal pathology and α-synuclein. Germ-free conditions prevented the NET and α-synuclein differences, implicating the microbiota.
Mechanistic data link LRRK2 kinase activity to RAB10 phosphorylation and an MPO–HOCl–dependent NET release pathway. The findings are mechanistic and preclinical (mouse and cell models) and do not demonstrate clinical effects in people with Parkinson’s disease or IBD.
They generate hypotheses about neutrophil programming, NETs, and microbiota involvement at the gut–brain axis that could inform future translational studies or biomarker work.
Preclinical mouse and cell-model study; not clinical evidence. Structured content depth is abstract from the posted article; findings require replication and human validation.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The article connects psoriasis and Crohn's disease through shared immune pathways and the gut-skin axis, which may matter because people with one condition could have signs or risks related to the other. It emphasizes...
The study suggests a specific microbial metabolite, 3‑HPA, can link cold exposure to worse colitis by changing the microbiome and harming epithelial cell mitochondria and barrier function — a possible new mechanistic...
This preclinical study links cod skin–derived collagen peptides to reduced colitis severity in mice through changes in the gut microbiota and suppression of the NLRP3 inflammasome — pathways that could be relevant to...
